Decision support for defibrillator placement in hypertrophic cardiomyopathy
Part of Heart & circulation clinical trials.
This trial looks at how to make better decisions about whether someone with hypertrophic cardiomyopathy (HCM) should get an implantable heart defibrillator. It may help by using structured decision support to guide defibrillator implantation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 16 years old
- You have a diagnosis of hypertrophic cardiomyopathy (HCM) based on heart muscle thickness (about 15 mm in adults, or 13 mm in adult relatives)
- You either do not have a defibrillator, or you have one placed for prevention before a serious event (not after an event)
- You have heart muscle thickness due to typical HCM, not a specific other cause like amyloidosis
- You must be covered by social security insurance
- You should not have a defibrillator placed for secondary prevention (after an aborted sudden cardiac arrest or a sustained dangerous heart rhythm)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares modern heart failure medications and implantable cardioverter-defibrillators (ICDs) to reduce the risk of sudden cardiac death in people with a specific type of heart muscle disease (non-ischemic cardiomyopathy) that is not caused by blocked arteries. It may help guide treatment decisions for those with a weakened heart and certain scarring on heart MRI.
This study looks at whether using a heart MRI (CMR) to guide where to place an implanted defibrillator (ICD) improves outcomes for people with a weakened heart muscle caused by non-ischemic dilated cardiomyopathy. It’s for adults who have low pumping strength and evidence of heart scarring on MRI.
This study looks at whether implantable defibrillators can reduce dangerous heart rhythms in people with non-ischemic cardiomyopathy (heart weakness not caused by blocked heart arteries), a heart scar, and very low pumping strength despite best treatment. It compares different approaches to choosing which patients should receive these devices.
This study looks at whether a special type of defibrillator that sits under the skin is a good option for people with arrhythmogenic cardiomyopathy, a heart condition that can cause dangerous heart rhythms. It aims to help doctors decide who might benefit from this device and when.
This study uses an MRI scan of the heart to better identify which people with heart failure need a defibrillator along with a special pacemaker (cardiac resynchronization therapy). The scan may help doctors decide if the device could improve your heart's pumping and reduce risks.
This trial is testing a personalized approach to deciding who gets an implantable defibrillator (ICD) for people with heart failure due to dilated cardiomyopathy (not from blocked arteries). It aims to see if MRI scans and other factors can better match the device to those who need it most.
Hear when a new Hypertrophic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.